Use of the “Minnesota Living with Heart Failure Questionnaire” Quality of Life Questionnaire in Kosovo’s Heart Failure Patients

Artan Ahmeti, Pranvera Ibrahimi, Ibadete Bytyci, Edmond Haliti, Rozafa Olloni, Shpend Elezi, Gani Bajraktari


Background and aim: Quality of life (QoL) is one of the most important end-points in heart failure (HF) patients. The Minnesota Living with Heart Failure Questionnaire (MLHFQ) is the most widely used measurement for assessing the QoL in HF patients. We used this questionnaire to evaluate the QoL in HF patients in Kosovo.

Methods: The study subjects were 103 consecutive HF patients (63±10 years, 56 female) admitted in outpatient or in-patient clinics at University Clinical Centre of Kosovo. At the moment of evaluation the patients were clinically stable and on optimized drug therapy. 

Results: The overall median score of MLHFQ was 51 (mean 50±18). Female patients had higher total (p=0.015), emotional (p=0.022) and physical (p=0.019) MLWH compared to male patients. Te total MQLQ score had good correlation with 6MWT distance (p<0.001), but not with the level of NTproBNP level (p=0.364). Significant relationship was found also between MLWH and NYHA functional class in HF patients (p=0.002 for total, p=0.026 for emotional, and p<0.001 for physical MLHF score). NYHA functional class also significantly correlated with 6MWT distance (p<0.001 for both). 

Conclusions: The Albanian version of the MLHFQ proposed in this study proved to be valid for HF patients and served as a new and important instrument for assessing QoL in Kosovo’s patients. The MLHFQ was mildly higher in our patients compared with previous studies and was higher in female patients. The questionnaire score correlates with functional NYHA class, reflecting the severity of the disease, and with 6 minute walk test, reflecting exercise capacity.   


Heart Failure, Quality of Life, Minnesota

Full Text:



Bajraktari G, Kurtishi I, Rexhepaj N, Tafarshiku R, Ibrahimi P, Jashari F, et al. Gender related predictors of limited exercise capacity in heart failure. IJC Heart Vessels. 2013 Dec;1:11–6; DOI:

Chizzola PR, Gonçalves de Freitas HF, Marinho NVS, Mansur JA, Meneghetti JC, Bocchi EA. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure. Int J Cardiol. 2006 Jan 4;106(1):29–34; DOI: 10.1016/j.ijcard.2004.12.050

Carvalho VO, Guimarães GV, Carrara D, Bacal F, Bocchi EA. Validation of the Portuguese version of the Minnesota Living with Heart Failure Questionnaire.Arq Bras Cardiol. 2009 Jul;93(1):39–44;

Bytyçi I, Bajraktari G. Mortality in heart failure patients. Anatol J Cardiol. 2015 Jan;15(1):63–8; DOI: 10.1111/echo.13306

Ibrahimi P. Predictors of exercise capacity in heart failure. IntCardiovasc Forum J. 2015 Mar 29;1(1):37; DOI:

McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart Br Card Soc. 2000 May; 83(5):596–602; DOI: 10.1136/heart.83.5.596

Parajón T, Lupón J, González B, Urrutia A, Altimir S, Coll R, et al. [Use of the Minnesota Living With Heart Failure Quality of Life Questionnaire in Spain]. Rev EspCardiol. 2004 Feb;57(2):155–60; DOI: 10.1016/S1885-5857(10)70276-0

McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012 Aug;14(8):803–69; DOI: 10.1093/ eurheartj/ehs104

Hoekstra T, Lesman-Leegte I, van Veldhuisen DJ, Sanderman R, Jaarsma T. Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction. Eur J Heart Fail. 2011 Sep;13(9):1013–8; DOI: 10.1093/eurjhf/hfr072

Lesman-Leegte I, Jaarsma T, Coyne JC, Hillege HL, Van Veldhuisen DJ, Sanderman R. Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls. J Card Fail. 2009 Feb;15(1):17–23; DOI: 10.1016/j.cardfail.2008.09.006

Stevenson LW. Design of therapy for advanced heart failure. Eur J Heart Fail. 2005 Mar 16;7(3):323–31; DOI: 10.1016/j.ejheart.2005.01.004

Jaarsma T, Beattie JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009 May;11(5):433–43; DOI: 10.1093/eurjhf/hfp041

Iqbal J, Francis L, Reid J, Murray S, Denvir M. Quality of life in patients with chronic heart failure and their carers: a 3-year follow-up study assessing hospitalization and mortality. Eur J Heart Fail. 2010 Sep;12(9):1002–8; DOI: 10.1093/eurjhf/hfq114

Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992 Oct;124(4):1017–25; DOI:

Bajraktari G. The Kosovo Society of Cardiology. IntCardiovasc Forum J [Internet]. 2015 May 12 [cited 2016 Sep 18];2(1). Available from:; DOI: 10.17987/icfj.v2i1.93

Ingle L, Rigby AS, Nabb S, Jones PK, Clark AL, Cleland JGF. Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease. Eur J Heart Fail. 2006 May;8(3):321–5; DOI: 10.1016/j.ejheart.2005.08.006

Dobre D, de Jongste MJL, Haaijer-Ruskamp FM, Sanderman R, van Veldhuisen DJ, Ranchor AV. The enigma of quality of life in patients with heart failure. Int J Cardiol. 2008 Apr 25;125(3):407–9; DOI: 10.1016/j.ijcard.2007.01.044

Austin BA, Wang Y, Smith GL, Vaccarine V, Krumholz HM, McNamara RL. Systolic function as a predictor of mortality and quality of life in long-term survivors with heart failure. Clin Cardiol. 2008 Mar;31(3):119–24; DOI: 10.1002/clc.20118

Ruiz Comellas A, Pera G, BaenaDíez JM, MundetTudurí X, AlzamoraSas T, Elosua R, et al. [Validation of a Spanish Short Version of the Minnesota Leisure Time Physical Activity Questionnaire (VREM)]. Rev EspSaludPública. 2012 Oct;86(5):495–508;

Brokalaki H, Patelarou E, Giakoumidakis K, Kollia Z, Fotos NV, Vivilaki V, et al. Translation and validation of the Greek “Minnesota Living with Heart Failure” questionnaire. Hell J Cardiol HJC HellēnikēKardiologikēEpitheōrēsē. 2015 Feb;56(1):10–9.

Moon JR, Jung YY, Jeon E-S, Choi J-O, Hwang JM, Lee S-C. Reliability and validity of the Korean version of the Minnesota Living with Heart Failure Questionnaire. Heart Lung J Crit Care. 2012 Feb;41(1):57–66; DOI: 10.1016/j.hrtlng.2011.09.011

Huang T-Y, Moser DK, Hsieh Y-S, Lareau SC, Durkin AC, Hwang S-L. Validation of Chinese version of the Modified Pulmonary Functional Status and Dyspnea Questionnaire with heart failure patients in Taiwan. Am J Crit Care Off Publ Am Assoc Crit-Care Nurses. 2008 Sep;17(5):436–42; DOI: 10.1111/j.1365-2702.2008.02294.x

Naveiro-Rilo JC, Diez-Juárez DM, Romero Blanco A, Rebollo-Gutiérrez F, Rodríguez-Martínez A, Rodríguez-García MA. Validation of the Minnesota living with heart failure questionnaire in primary care. Rev EspCardiol. 2010 Dec;63(12):1419–27; DOI: 10.1016/S1885-5857(10)70276-0

Santos JJA dos, Plewka JEA, Brofman PRS. Quality of life and clinical indicators in heart failure: a multivariate analysis. Arq Bras Cardiol. 2009 Aug;93(2):159–66;

Garin O, Ferrer M, Pont A, Rué M, Kotzeva A, Wiklund I, et al. Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2009 Feb;18(1):71–85; DOI: 10.1007/s11136-008-9416-4

Carvalho EEV de, Costa DC, Crescêncio JC, Santi GLD, Papa V, Marques F, et al. Heart failure: comparison between six-minute walk test and cardiopulmonary test. Arq Bras Cardiol. 2011 Jul;97(1):59–64;

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4

Copyright (c) 2017 Gani Bajraktari

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.